Cargando…

Metastatic Progression of Human Melanoma

Detalles Bibliográficos
Autores principales:	Tímár, József, Ladányi, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954442/ https://www.ncbi.nlm.nih.gov/pubmed/36831566 http://dx.doi.org/10.3390/cancers15041225

Ejemplares similares

Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy Prediction
por: Tímár, József, et al.
Publicado: (2022)

Identification of a Tumor Cell Associated Type I IFN Resistance Gene Expression Signature of Human Melanoma, the Components of Which Have a Predictive Potential for Immunotherapy
por: Ladányi, Andrea, et al.
Publicado: (2022)

HLA Class I Downregulation in Progressing Metastases of Melanoma Patients Treated With Ipilimumab
por: Ladányi, Andrea, et al.
Publicado: (2022)

Overview of Subcutaneous Metastatic Melanoma
por: Mozzillo, Nicola
Publicado: (2021)

From Melanocyte to Malignant Metastatic Melanoma
por: Manga, Prashiela, et al.
Publicado: (2010)

Metastatic melanoma and vemurafenib: novel approaches
por: De Mello, Ramon Andrade
Publicado: (2012)

Novel treatment paradigms for metastatic uveal melanoma
por: Patel, Sapna P., et al.
Publicado: (2022)

Organ Specific Copy Number Variations in Visceral Metastases of Human Melanoma
por: Papp, Orsolya, et al.
Publicado: (2021)

Demonstration of a Melanoma-Specific CD44 Alternative Splicing Pattern That Remains Qualitatively Stable, but Shows Quantitative Changes during Tumour Progression
por: Raso-Barnett, Livia, et al.
Publicado: (2013)

Metastatic Malignant Melanoma of the Gastrointestinal Tract: Too Dark to be Seen?
por: Chaves, Jéssica, et al.
Publicado: (2022)

The importance of microenvironment: the role of CCL8 in metastasis formation of melanoma
por: Barbai, Tamás, et al.
Publicado: (2015)

KIT Mutation Incidence and Pattern of Melanoma in Central Europe
por: Doma, V., et al.
Publicado: (2019)

Editorial on Special Issue “Advances and Novel Treatment Options in Metastatic Melanoma”
por: Carè, Alessandra, et al.
Publicado: (2022)

Special Issue “Precision Oncology in Melanoma Progression”
por: D’Aguanno, Simona
Publicado: (2021)

Pin1–FOXM1 inhibitors: a potential therapeutic for metastatic melanoma?
por: de Keizer, Peter LJ
Publicado: (2016)

Genetics and Genomics of Melanoma: Current Progress and Future Directions
por: Quek, Camelia
Publicado: (2023)

Prenylation Inhibition-Induced Cell Death in Melanoma: Reduced Sensitivity in BRAF Mutant/PTEN Wild-Type Melanoma Cells
por: Garay, Tamás, et al.
Publicado: (2015)

Molecular epidemiology and diagnostics of KRAS mutations in human cancer
por: Timar, Jozsef, et al.
Publicado: (2020)

Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression
por: Bánky, Balázs, et al.
Publicado: (2012)

Evolving Acquired Vemurafenib Resistance in a BRAF V600E Mutant Melanoma PDTX Model to Reveal New Potential Targets
por: Tóvári, József, et al.
Publicado: (2023)

Recent Progress in the Diagnosis and Treatment of Melanoma and Other Skin Cancers
por: Pawlik, Laura, et al.
Publicado: (2023)

Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma
por: Doma, V., et al.
Publicado: (2019)

Correction to: Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma
por: Doma, V., et al.
Publicado: (2019)

On-Target Side Effects of Targeted Therapeutics of Cancer
por: Tímár, József, et al.
Publicado: (2022)

Macrophages as prognostic biomarkers in human melanoma
por: Samaniego, Rafael, et al.
Publicado: (2018)

EGFR Protein Expression in KRAS Wild-Type Metastatic Colorectal Cancer Is Another Negative Predictive Factor of the Cetuximab Therapy
por: Uhlyarik, Andrea, et al.
Publicado: (2020)

Increased HOX C13 expression in metastatic melanoma progression
por: Cantile, Monica, et al.
Publicado: (2012)

The Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome Sequencing Discoveries
por: Pipek, Orsolya, et al.
Publicado: (2023)

Cancer Genomics: Large-Scale Projects Translate into Therapeutic Advances
por: Mardis, Elaine R., et al.
Publicado: (2016)

c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression
por: Ganguly, Sourik S., et al.
Publicado: (2011)

Mda-9/Syntenin Is Expressed in Uveal Melanoma and Correlates with Metastatic Progression
por: Gangemi, Rosaria, et al.
Publicado: (2012)

Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma
por: Li, Yuanyuan, et al.
Publicado: (2019)

Biophysical characterization of melanoma cell phenotype markers during metastatic progression
por: Sobiepanek, Anna, et al.
Publicado: (2021)

Angiogenesis and Progression in Human Melanoma
por: Ria, R., et al.
Publicado: (2010)

Application of black salve to a thin melanoma that subsequently progressed to metastatic melanoma: a case study
por: Sivyer, Graham W., et al.
Publicado: (2014)

Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanoma
por: Hassel, Jessica C., et al.
Publicado: (2017)

Imaging of metastatic melanoma
por: Michael King, D
Publicado: (2006)

Metastatic melanoma to the testis
por: Patnana, Madhavi, et al.
Publicado: (2018)

Lymphatic density and metastatic spread in human malignant melanoma
por: Shields, J D, et al.
Publicado: (2004)

Epigenetic Impacts of Ascorbate on Human Metastatic Melanoma Cells
por: Venturelli, Sascha, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1l4s86l4sk4sfgh0fh5bn6emte